we evaluated the efficacy of flecainide acetate ( given intravenously to a maximal dose of 2 mg kg-1 and then orally in a dose of 100 mg b.d . or 100 mg t.d.s . ) in the conversion to sinus rhythm of 50 patients exhibiting supraventricular arrhythmias ( 39 with atrial fibrillation , 6 with atrial flutter , 4 with supraventricular tachycardia and one with supraventricular tachycardia in association with the wolff-parkinson-white syndrome ) .
C0086303
flecainide acetate
C0039240
supraventricular